185 related articles for article (PubMed ID: 7053713)
1. Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma.
Santen RJ; Worgul TJ; Lipton A; Harvey H; Boucher A; Samojlik E; Wells SA
Ann Intern Med; 1982 Jan; 96(1):94-101. PubMed ID: 7053713
[TBL] [Abstract][Full Text] [Related]
2. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
Samojlik E; Santen RJ; Kirschner MA; Ertel NH
Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
6. Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Wells SA; Santen RJ; Lipton A; Haagensen DE; Ruby EJ; Harvey H; Dilley WG
Ann Surg; 1978 May; 187(5):475-84. PubMed ID: 646874
[TBL] [Abstract][Full Text] [Related]
7. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
Sterns EE; Bird CE; Mackie KW
Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
[TBL] [Abstract][Full Text] [Related]
8. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
Samojlik E; Veldhuis JD; Wells SA; Santen RJ
J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
10. A phase II evaluation of combination chemotherapy plus aminoglutethimide in women with metastatic or recurrent breast carcinoma. An Eastern Cooperative Oncology Group Pilot Study.
Grem JL; Falkson G; Love RR; Tormey DC
Am J Clin Oncol; 1988 Oct; 11(5):528-34. PubMed ID: 3177253
[TBL] [Abstract][Full Text] [Related]
11. Aminoglutethimide for the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE; Coombes RC; Ford HT; Gazet JC; Harmer CL; Morgan M; White H; Parsons CA; McKinna JA
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):11-17. PubMed ID: 6682769
[TBL] [Abstract][Full Text] [Related]
12. Aminoglutethimide in the treatment of metastatic breast cancer.
Troner MB
Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings.
Kahán Z; Tóth I; Vecsernyés M
Oncology; 1992; 49(1):31-4. PubMed ID: 1542490
[TBL] [Abstract][Full Text] [Related]
14. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.
Santen RJ
Breast Cancer Res Treat; 1981; 1(3):183-202. PubMed ID: 6293627
[TBL] [Abstract][Full Text] [Related]
15. Pros and cons of aminoglutethimide for advanced postmenopausal breast cancer.
Bruning PF; Bonfrèr JG; Engelsman E; Hamersma-vd Linden E; de Jong-Bakker M; Nooyen W
Breast Cancer Res Treat; 1984; 4(4):289-95. PubMed ID: 6518295
[TBL] [Abstract][Full Text] [Related]
16. The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast.
Santen RJ; Wells SA
Cancer; 1980 Aug; 46(4 Suppl):1066-74. PubMed ID: 6249490
[No Abstract] [Full Text] [Related]
17. Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Santen RJ; Samojlik E; Lipton A; Harvey H; Ruby EB; Wells SA; Kendall J
Cancer; 1977 Jun; 39(6 Suppl):2948-58. PubMed ID: 194681
[TBL] [Abstract][Full Text] [Related]
18. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
Samojlik E; Santen RJ
J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
[TBL] [Abstract][Full Text] [Related]
19. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
Harris AL; Powles TJ; Smith IE
Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
[TBL] [Abstract][Full Text] [Related]
20. Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
Zambetti M; Brambilla C; Tancini G; Bonadonna G
Tumori; 1987 Aug; 73(4):369-73. PubMed ID: 3660475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
